Urdu Version of Menopause-specific Quality of Life Scale

Sponsor
Riphah International University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05913648
Collaborator
(none)
290
1
6.5
44.4

Study Details

Study Description

Brief Summary

Menopause is accompanied by a spectrum of symptoms that are frequently related to hormonal changes. Menopause and its symptoms frequently have an impact on postmenopausal women's Quality of Life. There is a need for culturally adapted screening tool to aid healthcare professionals or clinicians to screen the symptoms of menopausal women, so the aim of this study is to translate the Menopause specific quality of life (MENQOL) into Urdu and to find the reliability and validity of the translated version Menopause specific quality of life in menopausal women.

Condition or Disease Intervention/Treatment Phase
  • Other: Tool Translation

Detailed Description

Menopause is accompanied by a variety of physiological changes and symptoms, including hot flashes, nightly sweating, anxiety, headaches, vaginal dryness, lethargy, irritability, and sleep disturbance. Menopause and its symptoms frequently have an impact on postmenopausal women's quality of life, a metric that is influenced by a variety of societal and personal circumstances. The Menopause-Specific Quality of Life Questionnaire(MENQOL) evaluates the prevalence and severity of bothersome physical and psychological concerns that women could experience during the menopausal transition.

As cross-border and cross-cultural studies continue to increase, there is a greater need for linguistic validation of tools in various societies. Until now no translation or adaptation of the MENQOL questionnaire has been made for the population with different languages in Pakistan. There is a need for culturally adapted screening tools to aid healthcare professionals or clinicians to screen the symptoms of menopausal women in the Pakistani population. As the Urdu language is Pakistan's national language so commonly used all over Pakistan, so it is required to translate and culturally adapt the MENQOL scale into Urdu language for the Pakistani population.

Study Design

Study Type:
Observational
Anticipated Enrollment :
290 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Urdu Translation, Validity and Reliability of Menopause-specific Quality of Life Scale
Anticipated Study Start Date :
Jun 15, 2023
Anticipated Primary Completion Date :
Oct 30, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Outcome Measures

Primary Outcome Measures

  1. Menopause-specific quality of life (MENQOL) [Baseline]

    The Menopause-Specific Quality of Life (MENQOL) questionnaire is a tool designed to assess the quality of life of women who are experiencing menopause. It consists of 29 items that measure the impact of menopausal symptoms on four domains: vasomotor (item 1-3). Psychological (items 4-10), physical (items 11-26) and sexual (items 27-29). The higher score indicates the symptom is more bothersome whereas the lower score indicates the symptoms are not at all bothered.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 70 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Natural Menopause

  • Females who are able to speak and read Urdu

  • Volunteer to participate in the study

Exclusion Criteria:
  • Mental in capacity to complete a self-administered questionnaire

  • Communication problem

  • Taking treatment for menopausal symptoms

  • History of hysterectomy or ovariectomy

  • Any systemic Chronic diseases affecting quality of life

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ghosia medical center Rawalpindi Pakistan 46000

Sponsors and Collaborators

  • Riphah International University

Investigators

  • Principal Investigator: Huma Riaz, PHD*, Riphah International University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Huma Riaz, Associate Professor, Riphah International University
ClinicalTrials.gov Identifier:
NCT05913648
Other Study ID Numbers:
  • RiphahIU Khansa Ishaq
First Posted:
Jun 22, 2023
Last Update Posted:
Jun 22, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jun 22, 2023